ASH 2020 Updates in AML 

Dr. Eunice Wang – Roswell Comprehensive Cancer Center (Buffalo, NY)

Dr. Eunice Wang – Roswell Comprehensive Cancer Center

Dr. Eunice Wang is the Chief of the Leukemia Service and Professor of Oncology in the Department of Medicine at Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA. She is also Medical Director of Chemotherapy/Infusion Services and Director of the Roswell Park Hematological Procurement Shared Resource. In addition, she has an appointment as an Associate Professor, Department of Medicine, Jacobs School of Medicine & Biomedical Sciences at the University of Buffalo (State University of New York). Dr. Wang earned her medical degree from the Keck School of Medicine, University of Southern California and completed residency training in Internal Medicine at Yale-New Haven Hospital, Yale University, New Haven, CT. She completed a clinical hematology-oncology and research fellowship at Memorial Sloan Kettering Cancer Center in New York, NY. Dr. Wang’s research focuses on translation of promising agents into therapies for acute leukemias (AML, ALL) and myeloid malignancies (MDS, MPN). She has authored/co-authored over 100 peer-reviewed articles, book chapters, and editorials and previously served on the National Comprehensive Cancer Network (NCCN) guideline panels for AML, ALL, and MPN for several years. She is a prior recipient of a NIH Cancer Clinical Investigator Team Leadership Award (CCITLA) and a Mentored Research Scholar award from the American Cancer Society.

Thank you to our WHU 2021 Sponsors